论文信息 - Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targeting. - 字舞流文

Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targeting.

S. Thomas | M. Manspeaker | Lauren F. Sestito | A. Schudel | D. M. Francis | P. A. Archer | Alexander J. Heiler | David M. Francis | Margaret P. Manspeaker | Paul A. Archer